The two-day conference will see national level participation from over 200 pharmacists from the UAE and GCC countries During the conference. Organized under the patronage of H.E. Abdul Rahman Al Owais, UAE Minister of Health, the Fifth National ... AME Info, 3 weeks ago
Ministry of Health and Sanofi strengthen resolve to build a robust pharmacovigilance environment in UAE - GulfNews247.com, 3 weeks ago
UAE's pharmacovigilance infrastructure in focus - Trade Arabia, 3 weeks ago
2 images for "sanofi country"
06:31 AM EDT SEELOW, BRANDENBURG - AUGUST 08: Country doctor Dieter Baermann measures the blood sugar level of an elderly patient in the patient's home on August 8, 2011 in Sachsendorf near Seelow, Germany. Baermann works in the state of ...Latinos Health, 1 month ago
Source: Regeneron. Investors in healthcare giants Regeneron Pharmaceuticals ( NASDAQ:REGN ) and Sanofi ( NYSE:SNY ) were given anotherreason to smile earlier today as the companies officially announced that the EuropeanCommission has granted ...Motley Fool, 1 week ago Regeneron Announces Collaboration With Mitsubishi Tanabe Pharma For Investigational Pain Therapy Fasinumab In Asia TheStreet.com, 1 week ago
Summary Sanofi is taking a smart, tactical approach to its Afrezza launch. Label enhancements and widespread insurance coverage must come before full DTC launch. Patience is a virtue: Remember that. MannKind Investors should sit tight. ...Seeking Alpha, 1 week ago
Sanofi, the French drugmaker settled a lawsuit over patents for Lantus SoloStar, its once-daily insulin in a pen-like injector on September 28. Sanofi's Lantus is a less expensive version of the world's top selling insulin that could go on sale in ...MedIndia, 1 week ago
Zealand Informs That Sanofi's New Drug Application For Lixisenatide (Lyxumia(R)) Has Been Accepted For Review By The FDA
COPENHAGEN, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Zealand informs that Sanofi today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for lixisenatide in the U.S. As stated earlier, Sanofi ...TheStreet.com, 1 week ago Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA TeleTrader.com, 1 week ago Lixisenatide (Lyxumia) royalty revenue increased in Q2 2015 as Sanofi confirms the submission of a NDA in the US [Saudi Press Agency (Saudi Arabia)] Pharmacy Choice, 2 months ago
The way Arun Jaitley is showing proactiveness now in solving the tax cases, the revenue department's appeal in the Sanofi case may just be a matter of routine handling of the cases pursued by the income tax department. (PTI) Whether Prime ...Financial Express, 1 week ago Retro tax mess: Arun Jaitley gets act together, big boost for Narendra Modi govt expected Financial Express, 1 week ago
Novo Nordisk A/S (ADR) (NYSE: NVO ) and Sanofi SA (ADR) (NYSE: SNY ) are two healthcare companies that recently received product approval in the US and Europe, respectively, but both stocks did not move significantly, in line with the news. In the ...InsiderMonkey.com, 1 week ago
New Delhi: The Supreme Court on Tuesday admitted the income tax department's appeal against a 2013 Andhra Pradesh high court ruling that said that France-based Sanofi SA was not required to pay tax in India for its acquisition of Hyderabad-based ...Livemint.com, 2 weeks ago
Shin Seong-suk, compliance director at France-based pharmaceutical company Sanofi-Aventis Korea, sent her 11-year-old son Lee Yu-jin to Paris this summer to spend 10 days with a French family she had never met before. Last week, she welcomed ...Korea Herald, 1 month ago Why drug companies are betting big on pharmerging countries Fortune, 1 month ago Pharmaceutical companies see a big market in "pharmerging" nations Fortune, 1 month ago
on your WebpageAdd Widget >Get your members hooked!